Exploring the feasibility of using the ICER Evidence Rating Matrix for Comparative Clinical Effectiveness in assessing treatment benefit and certainty in the clinical evidence on o...

por Wex, Jaro, Szkultecka-Debek, Monika, Drozd, Mariola, King, Sarah, Zibelnik, Natasa
Publicado 2023

Symptom burden in patients with idiopathic multicentric Castleman disease and its impact on daily life: an international patient and caregiver survey

por Mukherjee, Sudipto, Shupo, Francis, Wayi-Wayi, Grace, Zibelnik, Natasa, Jones, Emily, Mason, Nicola, Franklin, Matthew, Brazier, John
Publicado 2023

Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease

por Shupo, Francis, Abrams, Keith R., Ademi, Zanfina, Wayi-Wayi, Grace, Zibelnik, Natasa, Kirchmann, Matt, Rutherford, Carolyn, Makarounas-Kirchmann, Kelly
Publicado 2023